Company profile: Patheon
1.1 - Company Overview
Company description
- Provider of commercial manufacturing and pharmaceutical development services to pharmaceutical and biotechnology industries worldwide, spanning solid, semi-solid, liquid, and sterile dosage forms. Offers contract development and manufacturing from preclinical to commercialization, clinical trial strategy and operations, commercial services, advanced therapies (viral vectors, cell therapy, mRNA), biologics, and small molecule development and manufacturing.
Products and services
- Contract Development and Manufacturing: Delivers integrated, preclinical-to-commercial services for small and large molecules, spanning development and manufacturing across solid, semi-solid, liquid, and sterile dosage forms
- Biologics: Engineers scalable development and manufacturing for biologics using fed-batch, perfusion, and XD technologies to produce processes optimized for efficient scale-up
- Advanced Therapies: Offers specialized development and manufacturing for advanced therapies, including viral vectors, cell therapy, and mRNA, coordinating modality-specific processes for these modalities
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Patheon
Therapak
HQ: United States
Website
- Description: Provider of diagnostic and medical device kitting services for clinical trials and healthcare, including protocol management, kit development, global distribution, and configurable collection kits, supported by PASSPORT online systems. Offers clinical supply packaging for temperature-sensitive shipments, specialized specimen collection and transport products, including customizable test-specific kits and temperature-controlled shipping systems, and an online hazardous materials training course.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Therapak company profile →
UBC
HQ: United States
Website
- Description: Provider of pharmaceutical support services for life science companies, including evidence development, safety and risk management, patient access, technology solutions, and clinical services. UBC leverages real-world data, technology, and analytics to enhance late-stage research, demonstrate safety, improve access and adherence, and speed therapy initiation.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full UBC company profile →
TransCure BioServices
HQ: Switzerland
Website
- Description: Provider of predictive preclinical R&D services via fee-for-service access to humanized mouse platforms, including CD34+ humanized immune system, humanized liver, immuno-oncology, IBD, inflammatory disorder, and infectious disease (HIV, HBV) models, used to profile new drugs and assess efficacy/toxicity, drug-drug interactions, immunotherapies, and antivirals.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full TransCure BioServices company profile →
Quartesian
HQ: United States
Website
- Description: Provider of biostatistics, programming, and medical writing services, delivering customized, insightful data to organizations performing clinical studies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Quartesian company profile →
IDEA Pharma
HQ: United States
Website
- Description: Provider of strategic marketing, portfolio and disease area strategy, positioning, scenario planning and communication strategy for pharmaceutical companies, including path-to-market strategies addressing clinical, regulatory and commercial challenges; innovation strategy; strategic pharmaceutical positioning; Immersion, Design, Evaluation, Acceleration insights; and the annual Pharmaceutical Innovation and Invention Index.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full IDEA Pharma company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Patheon
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Patheon
2.2 - Growth funds investing in similar companies to Patheon
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Patheon
4.2 - Public trading comparable groups for Patheon
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →